Latest Clinical Trials
Many diseases, including pulmonary arterial hypertension, cut across various medical specialties and require multidisciplinary cooperation.
Pulmonary arterial hypertension, once considered a disease of the young, is increasingly affecting patients of older age.
Although our understanding of PAH has significantly improved, we are still far away from a definitive cure.
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
Clinical researchers are emphasizing the value of exercise in alleviating the symptoms of some diseases, including pulmonary arterial hypertension (PAH).
PAH Patient Perspectives
I live with pulmonary arterial hypertension (PAH), a progressive rare disease that is treated by addressing the symptoms only and not the disease.
In the summer of 2015, I had started to feel early symptoms of what would become a diagnosis of pulmonary arterial hypertension (PAH).
Rare Care Podcast
Noah Greenspan, DPT, founder of New York City’s Pulmonary Wellness & Rehabilitation Center, runs the nonprofit Pulmonary Wellness Foundation. In this interview, he talks about diagnosing and treating pulmonary arterial hypertension.
When 2 friends set out along Spain’s 500-mile Camino de Santiago, they didn’t know how many people they’d inspire with 3 little words: “I’ll Push You.”
Aytu BioPharma has developed an endotracheal respiratory catheter which its CEO says has “tremendous potential” in IPF, PAH, and other respiratory diseases.
When it comes to rare disorders, Israel—a New Jersey-sized nation of 9.3 million that’s made headlines this year for its highly successful coronavirus vaccination campaign—is clearly an emerging powerhouse.
Two important uses of the 6-MWT are pretreatment and posttreatment comparisons and predicting morbidity and mortality in patients with pulmonary hypertension
PAH Meeting Coverage